September 09, 2026
Mistral AI Raises β¬3B At β¬21B Valuation In Record European AI Round
Mistral AI, a Paris-based generative AI startup, has raised an impressive β¬3 billion in a Series D round led by Samsung, Scaleup Europe, and PSG Equity, valuing the company at β¬21 billion. This funding round highlights the growing importance and investment in sovereign AI capabilities in Europe, as countries and companies seek to establish independent AI infrastructures. The substantial investment underscores the confidence in Mistral's technology and its potential to drive innovation in the AI sector. The round also reflects the competitive landscape in AI funding, with European firms making significant strides.
New Funding Rounds
- Cymphony β $25M Series A co-led by Sequoia and SMBC Fin Atlas Beyond Fund (valued at over $100M, addressing enterprise security risks)
- CloudNC β $20M Series B extension (automating manufacturing bottlenecks)
- Bluecore Energy β $50M seed round (nuclear startup, raised shortly after coming out of stealth)
- Poseidon Aerospace β $60M (preparing for pilotless cargo aircraft test flight)
- GenHealth.ai β $16.5M Series A (developing back-office AI agents for healthcare)
New Product Launches
Personal Health Tech
- Oura β Files to go public with $1.2B in earnings (aims to expand AI-driven preventive health platform)
- Nanit β Leadership expansion with hires from WHOOP and ΕURA (signaling growth phase)
- Los Angeles Dodgers and ΕURA β Announce multi-year partnership (expanding health tech in sports)
- Zwift β Fall 2026 update includes WHOOP support (enhancing fitness tracking capabilities)
Notable Takes
The debate over AI's potential risks continues to heat up. Anthropic researchers have voiced concerns about the existential threats posed by self-improving AI, with one researcher resigning in protest. Meanwhile, Connor Leahy of ControlAI argues that superintelligent AI should be viewed as an adversary rather than a tool.
Industry Moves
Significant industry moves include Tailwind Labs joining Shopify, signaling a strategic partnership in the tech ecosystem. Additionally, H1's acquisition of Defacto Health aims to enhance provider network intelligence, expanding its healthcare data capabilities.